Abnormal proteolytic processing of von Willebrand factor arg611 cys and arg 611 his

Thrombosis and Haemostasis

Volumn 77, Issue 1, 1997, Pages 174-182

  Nishikubo, Toshiya ^a   Christophe, Olivier ^a   Lavergne, Jean Maurice ^a   Obert, Bernadette ^a   Nonami, Kyoko ^b   Takahashi, Yukihiro ^b   Yoshioka, Akira ^b   Meyer, Dominique ^a   Girma, Jean Pierre ^a  

^a BICÊTRE HOSPITAL   (France)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DESMOPRESSIN; PLASMA PROTEIN; PROTEIN SUBUNIT; RISTOCETIN; VON WILLEBRAND FACTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ELECTROPHORESIS; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INTRAVENOUS DRUG ADMINISTRATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; THROMBOCYTE; THROMBOCYTE COUNT;

EID: 0031043065     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1655927     Document Type: Article

References (42)

1. Ruggeri ZM, Ware J. The structure and function of von Willebrand Factor. Thromb Haemost 1992; 67: 594-9.
2. Meyer D, Girma JP. von Willebrand Factor - structure and function. Thromb Haemost 1993; 70: 99-104.
3. Chopek MW, Girma JP, Fujikawa K, Davie EW, Titani K. Human von Willebrand Factor: a multivalent protein composed of identical subunits. Biochemistry 1986; 25: 3146-55.
4. Titani K, Kumar S, Ericsson LH, Wade RD, Ashida K, Walsh KA, Chopek MW, Sadler JE, Fujikawa K. Amino acid sequence of human von Willebrand Factor. Biochemistry 1986; 25: 3171-84.
5. Andrews RK, Gorman JJ, Booth WJ, Corino GL, Castaldi PA, Berndt MC. Cross linking of a monomeric 39/34 kDa dispase fragment of von Willebrand Factor (Leu480/Val481-Gly718) to the N-terminal region of the α-chain of membrane glycoprotein Ib on the intact platelets with bis (sulfosuccinimidyl) suberate. Biochemistry 1989; 28: 8326-36.
6. Marti T, Rösselet SJ, Titani K, Walsh KA. Identification of disulfide-bridged substructures within human von Willebrand Factor. Biochemistry 1987; 26: 8099-109.
7. Zimmerman TS, Dent JA, Ruggeri ZM, Nannini LH. Subunit composition of plasma von Willebrand Factor. Cleavage is present in normal individuals, increased in type IIA and IIB von Willebrand disease, but minimal in variants with aberrant structure of individual oligomers (types IIC, IID, and IIE). J Clin Invest 1986; 77: 947-51.
8. Dent J A, Galbusera M, Ruggeri Z M. Heterogeneity of plasma von Willebrand Factor multimers resulting from proteolysis of the constituent subunit. J Clin Invest 1991; 88: 774-82.
9. Furlan M, Robles R, Lammle B. Partial purification and characterization of a protease from human plasma cleaving von Willebrand Factor to fragments produced by in vivo proteolysis. Blood 1996; 87: 4223-34.
10. Tsai HM. Physiologic cleavage of von Willebrand Factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood 1996; 87: 4235-44.
11. Berkowitz SD, Dent J, Roberts J, Fujimura Y, Plow EF, Titani K, Ruggeri ZM, Zimmerman TS. Epitope mapping of the von Willebrand Factor sub-unit distinguishes fragments present in normal and type HA von Willebrand disease from those generated by plasmin. J Clin Invest 1987; 79: 524-31.
12. Dent JA, Berkowitz SD, Ware J, Kasper CK, Ruggeri ZM. Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type HA von Willebrand Factor. Proc Natl Acad Sci USA 1990; 87: 6306-10.
13. Sadler JE. A revised classification of von Willebrand disease. Thromb Haemost 1994; 71: 520-5.
14. Lyons SE, Brack ME, Bowie EJW, Ginsburg D. Impaired intracellular transport produced by a subset of type-IIA von Willebrand disease mutations. J Biol Chem 1992; 267: 4424-30.
15. Hakami N, Shibuya H, Johnson GS, Stoy SJ, Huang THM, Montgomery RR. A novel von Willebrand Factor, Arg611Cys or vWF Columbia, associated with a dominant von Willebrand disease variant. Blood 1993; 82: 149a(abstr).
16. Castaman G, Eikenboom JCJ, Rodeghiero F, Briët E, Reitsma PH. A novel candidate mutation (Arg(611)→His) in type I 'platelet discordant' von Willebrand's disease with desmopressin-induced thrombocytopenia. Br J Haematol 1995; 89: 656-8.
17. Hubert L, Gaucher C, Mazurier C. Identification of two mutations (Arg611Cys and Arg611His) in the A1 loop of von Willebrand Factor (vWF) responsible for type 2 von Willebrand disease with decreased platelet-dependent function of vWF. Blood 1995; 86: 1010-8.
18. Weiss HJ, Pietu G, Rabinowitz R, Girma JP, Rogers J, Meyer D. Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand Factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease. J Lab Clin Med 1983; 101: 411-25.
19. Nishino M, Girma JP, Rothschild C, Fressinaud E, Meyer D. New variant of von Willebrand disease with defective binding to Factor VIII. Blood 1989; 5: 1591-9.
20. Weiss HJ, Meyer D, Rabinowitz R, Pietu G, Girma JP, Vicie WJ, Rogers J. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human Factor VIII/von Willebrand Factor and enhanced adsorption of its high-molecular-weight multimers. N Engl J Med 1982; 306: 326-33.
21. Allain JP, Cooper HA, Wagner RH, Brinkhous KM. Platelets fixed with paraformaldehyde: a new reagent for assay of von Willebrand Factor and platelet aggregating factor. J Lab Clin Med 1975; 85: 318-28.
22. Meyer D, Zimmerman TS, Obert B, Edgington TS. Hybridoma antibodies to human von Willebrand Factor. I. Characterization of seven clone. Br J Haematol 1984; 57: 597-608.
23. Christophe O, Ribba AS, Baruch D, Obert B, Rouault C, Niinomi K, Pietu G, Meyer D, Girma JP. Influence of mutations and size of multimers in type II von Willebrand disease upon the function of von Willebrand Factor. Blood 1994; 83: 3553-61.
24. Pietu G, Ribba A S, Cherel G, Siguret V, Obert B, Rouault C, Ginsburg D, Meyer D. Epitope mapping of inhibitory monoclonal antibodies to human von Willebrand Factor by using recombinant cDNA libraries. Thromb Haemost 1994; 71: 788-92.
25. Ardaillou N, Girma JP, Meyer D, Lavergne JM, Shoa'i I, Larrieu MJ. "Variants" of von Willebrand's disease. Demonstration of a decreased anti-genic reactivity by immunoradiometric assay. Thromb Res 1978; 12: 817-30.
26. Girma JP, Chopek MW, Titani K, Davie EW. Limited proteolysis of human von Willebrand Factor by staphylococcus aureus V-8 protease: isolation and partial characterization of a platelet-binding domain. Biochemistry 1986; 25: 3156-63.
27. Christophe O, Oben B, Meyer D, Girma JP. The binding domain of von Willebrand Factor to sulfatides is distinct from those interacting with glycoprotein Ib, heparin, and collagen and resides between amino acid residues Leu512 and Lys673. Blood 1991; 78: 2310-7.
28. Christophe O, Rouault C, Obert B, Pietu G, Meyer D, Girma JP. A monoclonal antibody (B724) to von Willebrand Factor recognizing an epitope within the A1 disulphide loop (Cys509-Cys695) discriminates between type 2A and type 2B von Willebrand disease. Br J Haematol 1995; 90: 195-203.
29. Takahashi Y, Kalafatis M, Girma JP, Meyer D. Abnormality of the N-terminal portion of von Willebrand Factor in type IIA and IIC von Willebrand disease. Thromb Haemost 1988; 60: 498-505.
30. Laemmli UK. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 1970; 227: 680-5.
31. O'Parrel PH. High resolution two-dimensional electrophoresis of proteins. J Biol Chem 1975; 250: 4007-21.
32. Towbin H, Stachelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350-4.
33. Johnson DA, Gautsch JW, Sportman JR, Elder JH. Improved technique utilizing nonfat dry milk for analysis of proteins and nucleic acids transferred to nitrocellulose. Gene Anal Techn 1984; 1: 3-8.
34. Hancock K, Tsang VCW. India ink staining of proteins on nitrocellulose paper. Anal Biochem 1983; 133: 157-62.
35. Ruggeri ZM, Zimmerman TS. The complex multimeric composition of Factor VIII/von Willebrand Factor. Blood 1981; 57: 1140-3.
36. Fraker PJ, Speck JC. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a, 6a-diphenylglycoluril. Biochem Biophys Res Commun 1978; 80: 849-57.
37. Ribba AS, Lavergne JM, Bahnak BR, Derlon A, Pietu G, Meyer D. Duplication of a methionine within the glycoprotein Ib binding domain of von Willebrand Factor detected by denaturing gradient gel electrophoresis in a patient with type-IIB von Willebrand disease. Blood 1991; 78: 1738-43.
38. Lavergne JM, Piao Y, Ribba AS, Girma JP, Siguret V, Pietu G, Boyer-Neumann C, Schandelong A, Bahnak BR, Meyer D. Functional analysis of the Arg91Gln substitution in the Factor-VIII binding domain of von Willebrand Factor demonstrates variable phenotypic expression. Thromb Haemost 1993; 70: 691-6.
39. Sambrook J, Friitsch EF, Maniatis T. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Publications. Cold Spring Harbor, NY, 1989.
40. Batlle J, Lasierra J, Villamor AF, Navarro JL, Pardo A, Campos M, Justice B, Fernandez MFL. Proteolytic processing of von Willebrand Factor subunit - heterogeneity in Type-IIA von Willebrand disease. Ann Hematol 1994; 68: 111-5.
41. Levene RB, Booyse FM, Chediak J, Zimmerman TS, Livingston DM, Lynch DC. Expression of abnormal von Willebrand Factor by endothelial cells from a patient with type IIA von Willebrand disease. Proc Natl Acad Sci USA 1987; 84: 6550-4.
42. Foster PA, Fulcher CA, Marti T, Titani K, Zimmerman TS. A major Factor VIII binding domain resides within the amino-terminal 272 amino acid residues of von Willebrand Factor. J Biol Chem 1987; 262: 8443-6.